BOOTS FUNGAL NAIL ONCE WEEKLY TREATMENT is a brand name for Amorolfine. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Treatment of mild cases of distal and lateral subungual onychomycoses caused by dermatophytes, yeasts and moulds limited up to 2 nails.
Verbatim from this product's MHRA label. Tap a section to expand.
Adults and Elderly The nail lacquer should be applied to the affected finger or toenails once weekly. The patient should apply the nail lacquer as follows: 1. Before the first application Amorolfine 5% w/v Medicated nail lacquer, it is essential that the affected areas of nail (particularly the nail surfaces) should be filed down as thoroughly as possible using a nail file, as supplied.
The surface of the nail should then be cleansed and degreased using an alcohol cleaning pad, as supplied. Cosmetic nail lacquer may be applied at least 10 minutes after Amorolfine 5% nail lacquer application. Before repeat application of Amorolfine 5% w/v Medicated nail lacquer, any remaining nail lacquer, and cosmetic nail lacquer if any, should be removed carefully.
Then, the affected nails should be filed down again as required before cleansing with an alcohol-soaked swab to remove any remaining lacquer.
Caution:
Nail files used for affected nails must not be used for healthy nails. 2. With one of the reusable applicators supplied, apply the nail lacquer to the entire surface of the affected nails and allow it to dry. After use, clean the applicator with the same cleaning pad used before for nail cleaning.
Keep the bottle tightly closed. For each nail to be treated, dip the applicator into the nail lacquer without wiping off any of the lacquer on the bottle neck. ) wear impermeable gloves in order to protect the Amorolfine 5% w/v Medicated nail lacquer on the nails.
Treatment should be continued without interruption until the nail is regenerated and the affected areas are finally cured. Non-compliance with frequency of administration and recommended treatment duration might result in treatment failure, and development of resistance.
The required frequency and duration of treatment depends essentially on the intensity and localisation of the infection. In general, it is six months (fingernails) and nine to twelve months (toenails). A review of the treatment is recommended at intervals of approximately three months.
If the infection has not cleared after six months (fingernails) and twelve months (toenails) medical advice should be sought. Co-existent tinea pedis should be treated with an appropriate antimycotic cream. Paediatric Population Due to the lack of clinical experience available, Amorolfine 5% w/v Medicated nail lacquer is not recommended for patients below the age of 18 years.
Adverse drug reactions are rare. g. nail discoloration, broken nails, brittle nails) may occur. These reactions can also be linked to the onychomycosis itself. System Organ Class Frequency Adverse drug reaction Immune system disorders Unknown frequency* Hypersensitivity (systemic allergic reaction)* Rare (≥1/10,000, <1/1000) Nail disorder, nail discoloration, onychoclasis (broken nails), onychorrhexis (brittle nails) Very rare (≤1/10,000) Skin burning sensation Skin and subcutaneous tissue disorders Unknown frequency* Erythema*, pruritus*, contact dermatitis*, urticaria*, blister* * Post marking experience Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Amorolfine 5% Medicated nail lacquer should not be applied on the skin around the nail. Avoid contact of the lacquer with eyes, ears and mucous membranes. Patients with underlying conditions predisposing to fungal nail infections should be referred to a doctor.
Such conditions include peripheral circulatory disorders, diabetes mellitus and immunosuppression. Patients with nail dystrophy, destroyed nail plate, nail pain or inflammation should be referred to their doctor. Owing to the lack of clinical experience available to date, children should not be treated with amorolfine 5% nail lacquer.
During the application of amorolfine no artificial nails should be used. After applying Amorolfine 5% Medicated nail lacquer, patients should wait at least 10 minutes before application of any cosmetic nail lacquer. Before repeat application of Amorolfine 5% Medicated nail lacquer, the cosmetic nail lacquer should be removed carefully.
When organic solvents are used impermeable gloves should be worn otherwise the amorolfine nail lacquer will be removed. A systemic or local allergic reaction could possibly occur after use of this product. If this happens, the product should be stopped immediately and medical advice should be sought.
Remove the product carefully by using a nail remover solution. The product should not be reapplied.
1.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Amorolfine in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.